Dr Reddys Laboratories share price

ABOUT Dr Reddys Laboratories

• Industry Biotechnology & Drugs
• ISIN INE089A01031
• BSE Code 500124
• NSE Code DRREDDY

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Dr Reddys Laboratories Management

• Kallam Reddy Chairman of the Board
• Gunupati Prasad Co-Chairman of the Board, Managing Director
• Erez Israeli Chief Executive Officer
• M. V. Narasimham Chief Financial Officer
• Patrick Aghanian Chief Executive Officer, European Generics
• Milan Kalawadia Chief Executive Officer, North America
• M. Ramana Chief Executive Officer, Branded Markets (India and Emerging Countries)
• Archana Bhaskar Chief Human Resource Officer
• Phani Mitra B. Chief Information Officer
• Sushrut Kulkarni Global Head of Integrated Product Development Organisation